Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the surveillance, epidemiology, and end results database, 1990–2008. Breast Cancer Res Treat. 2012;134(3):1257–68.

    Article  Google Scholar 

  2. Hieken TJ, Murphy BL, Boughey JC, Degnim AC, Glazebrook KN, Hoskin TL. Influence of biologic subtype of inflammatory breast cancer on response to neoadjuvant therapy and cancer outcomes. Clin Breast Cancer. 2018;18(4):e501–6.

    Article  Google Scholar 

  3. Kupstas AR, Hoskin TL, Day CN, Boughey JC, Habermann EB, Hieken TJ. Biological subtype, treatment response, and outcomes in inflammatory breast cancer using data from the National Cancer Database. Br J Surg. 2020;107(8):1033–41.

    Article  CAS  Google Scholar 

  4. Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet Oncol. 2014;15(6):640–7.

    Article  CAS  Google Scholar 

  5. Vagia E, Cristofanilli M. New treatment strategies for the inflammatory breast cancer. Curr Treat Options Oncol. 2021;22(6):50.

    Article  Google Scholar 

  6. Ge JY, Overmoyer B. Prolonged survival in patients with metastatic HER2-positive inflammatory breast cancer: a case report and review of the literature. Case Rep Oncol. 2021;14(2):1071-9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Mayo Clinic Alix School of Medicine, Rochester, MN, USA

    Tina J. Hieken MD, Judy C. Boughey MD & Amy C. Degnim MD

  2. Department of Radiology, Mayo Clinic, Rochester, MN, USA

    Katrina N. Glazebrook MBChB

  3. Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Rochester, MN, USA

    Tanya L. Hoskin MS

Authors
  1. Tina J. Hieken MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judy C. Boughey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amy C. Degnim MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katrina N. Glazebrook MBChB
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tanya L. Hoskin MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tina J. Hieken MD.

Ethics declarations

Disclosure

Judy Boughey had research collaboration with SymBioSis. The remaining authors have no relevant conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hieken, T.J., Boughey, J.C., Degnim, A.C. et al. Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy. Ann Surg Oncol 29, 5383–5386 (2022). https://doi.org/10.1245/s10434-022-12037-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12037-7

Search

Navigation